脑脊液
生物标志物
痴呆
医学
疾病
模态(人机交互)
病理
临床试验
重症监护医学
人工智能
计算机科学
生物
生物化学
作者
Suzanne E. Schindler,Alireza Atri
出处
期刊:Nature Aging
日期:2023-05-18
卷期号:3 (5): 460-462
被引量:6
标识
DOI:10.1038/s43587-023-00400-6
摘要
A major transformation in dementia diagnosis and care appears imminent and will depend on three major types of biomarkers: molecular imaging, blood-based biomarkers and cerebrospinal fluid biomarkers. Each modality has unique strengths and limitations that suggest its optimal uses in research, clinical trials and clinical diagnosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI